Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Opsoclonus-myoclonus Syndrome – a case report. (CROSBI ID 689476)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Pejić Roško, Sanja ; Đuranović, Vlasta ; Sekelj Fureš, Jadranka ; Lončar, Lana ; Đaković, Ivana ; Vulin, Katarina Opsoclonus-myoclonus Syndrome – a case report. // Clinical frontiers in pediatric neurology 2019, October 17th–18th, 2019, Ljubljana, Slovenia. Scientific programme and abstract book.. 2019. str. 35-36

Podaci o odgovornosti

Pejić Roško, Sanja ; Đuranović, Vlasta ; Sekelj Fureš, Jadranka ; Lončar, Lana ; Đaković, Ivana ; Vulin, Katarina

engleski

Opsoclonus-myoclonus Syndrome – a case report.

Opsoclonus myoclonus syndrome is defined by opsoclonus, myoclonus, and ataxia, behavioral and sleep problems. Mostly, it is paraneoplastic associated with different kind of cancers, in children mostly with neuroblastic tumors. Case Report: We report the case of a 2 -year-old girl who developed an ataxia without a known trigger.Hospital submission was necessary by persistent ataxia and suspected encephalitis. Different diagnostic tools (CCT, cMRI, lumbal puncture, search for auto antibodies, and virological diagnostic) showed normal results. The next days, the girl besides the ataxia showed muscular hypotonia, tremor, sleep and behavioral problems, and some strange ocular movements but not real opsoclonus. A neuroblastic tumor could not be found. Under therapy with dexamethasone (pulse, 20 mg/m2) which resulted in a good neurologic improvement. During the first three cycles, there was always a short worsening with recurrence of the ataxia , sleep disturbance and behavioral problems directly before dexamethasone was given. Meanwhile there is a constant improvement. We show videos from the first signs of opsoclonus myoclonus sy directly after first corticosteroid treatment up to the current state after 3 months.

opsoclonus-myoclonus syndrome

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

35-36.

2019.

objavljeno

Podaci o matičnoj publikaciji

Podaci o skupu

Clinical frontiers in pediatric neurology 2019, October 17th–18th, 2019, Ljubljana, Slovenia.

predavanje

17.10.2019-18.10.2019

Ljubljana, Slovenija

Povezanost rada

Kliničke medicinske znanosti